Université PSL

Personalized Medicine Conference

Personalized Medicine Conference
Date: 2016/07/10-15
Venue: Hong Kong University of Science and Technology

Patient response rates to chemotherapy are fairly low in cancer treatment, often due to human diversity and cancer heterogeneity. For almost all other diseases, the current population-averaged therapeutic approach is also hampered by the human diversity. Therefore, personalized medicine is necessary to improve treatment efficacy/response rate as well as safety by providing precisely tailored patient therapy. In this first GRC on "Personalized Medicine", we will review what we have achieved and how we should move forward.
Combinatorial treatment comprised of drugs, immunotherapy and radiations are commonly used in treating cancer, infectious disease and many other types of diseases for improving therapeutic outcomes and reduced drug resistance. Current methods are far from optimal. In addition, these combinatorial treatments will also vary from patient to patient.